Ivashko-Pachima, Yanina
Hadar, Adva
Grigg, Iris
Korenková, Vlasta
Kapitansky, Oxana
Karmon, Gidon
Gershovits, Michael
Sayas, C. Laura
Kooy, R. Frank http://orcid.org/0000-0003-2024-0485
Attems, Johannes
Gurwitz, David http://orcid.org/0000-0002-9363-1869
Gozes, Illana http://orcid.org/0000-0001-9796-2430
Article History
Received: 2 July 2018
Revised: 9 September 2019
Accepted: 12 October 2019
First Online: 30 October 2019
Compliance with ethical standards
:
: The use of ADNP and related mutations for AD diagnosis and for ADNP-related peptide/peptide mimetics AD/ASD treatment are under patent protection (I. Gozes., A.H., Y.I.-P.). I. Gozes also serves as the Chief Scientific Officer of Coronis Neurosciences, a company developing NAP (CP201) for the treatment of the ADNP syndrome.